Adhera Therapeutics Inc Sustainability Reports

Adhera Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs. Its pipeline candidates include treatments for Type 1 diabetes and Parkinson's disease.

Sector: Manufacturing

Country: United States

Exchange: OTC Markets

LEI: 5493002JYRNNJ4UY7Q16

FIGI: BBG001S7JBH8

No reports are currently available in our catalogue.